Niagen Bioscience, Inc.
NAGE· Nasdaq
NAGENiagen Bioscience, Inc.
Filed Nov 8, 2012 · 10-Q · 40 days after period end · 0001415889-12-001612
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $3.63M | $1.83M | $1.56M |
| Net Income | -$1.54M | -$2.40M | -$883.22K |
| EPS Diluted | -$0.02 | -$0.03 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR
ended Sep 29, 2012 · filed Nov 8, 2012 · 40 d after period end
